Oramed Pharmaceuticals
ORMP
#9008
Rank
C$0.19 B
Marketcap
C$4.76
Share price
0.88%
Change (1 day)
53.70%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): C$80.13 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are C$2 Million. In 2024 the company made an earning of -C$20.98 Million a decrease over its 2023 earnings that were of C$9.91 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$80.13 M-482.01%
2024 -C$20.98 Million-311.47%
2023 C$9.91 M-119.45%
2022 -C$51 Million39.17%
2021 -C$36.65 Million73.93%
2020 -C$21.07 Million18.53%
2019 -C$17.78 Million-16.62%
2018 -C$21.32 Million38.32%
2017 -C$15.42 Million12.51%
2016 -C$13.7 Million25.01%
2015 -C$10.96 Million18.18%
2014 -C$9.28 Million39.72%
2013 -C$6.64 Million46.4%
2012 -C$4.54 Million128.32%
2011 -C$1.99 Million-51.47%
2010 -C$4.1 Million35.21%
2009 -C$3.03 Million
2007 -C$4.76 Million607.04%
2006 -C$0.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
C$29.18 B 35,853.48%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
C$10.71 B 13,105.89%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-C$0.71 Billion-973.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-C$95.48 Million-217.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-C$38.38 Million-147.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel